[INM] QoQ Quarter Result on 30-Sep-2022 [#Q1]

Stock
[INM] InMed Pharmaceuticals Inc.
Announcement Date
14-Nov-2022
Financial Year
2023
Quarter
30-Sep-2022 [#Q1]
Profit Trend
QoQ- 55.40%
YoY- -18.10%
Quarter Report
INM's Result
INM's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 2,311 1,034 470 321 515 310 265 325.36%
PBT -337 -1,996 -2,098 -3,503 -7,870 -3,476 -4,283 -81.72%
Tax 2 2 3 7 -34 -31 22 -79.87%
NP -338 -1,998 -2,101 -3,510 -7,870 -3,476 -4,283 -81.68%
Tax Rate - - - - - - - -
Total Cost 2,649 3,032 2,571 3,831 8,385 3,785 4,548 -30.32%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -14.64 -193.24 -447.25 -1,094.24 -1,528.88 -1,122.69 -1,615.60 -95.69%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.10 -0.60 -0.91 -4.06 -302.39 -133.55 -7.73 -94.53%
EPS Diluted -0.10 -0.60 -0.91 -4.06 -302.39 -133.55 -7.73 -94.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.